1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Attenuation measurements on the different series with mean values, SDs, upper/lower 95% CIs of rater 1, and results from Wilcoxon tests between residual clots and perfused vessels in the 10 patients with residual clots
Hounsfield Attenuation (Mean) CT DEw VNC IM Clots 58.88 ± 10.98 50.50 ± 10.08 53.72 ± 9.42 16.02 ± 12.07 Lower/upper 95% CI of mean 55.05/70.66 43.29/57.71 46.98/60.46 7.39/24.65 Vessels 43.35 ± 5.54 49.37 ± 7.44 41.64 ± 7.87 10.88 ± 11.35 Lower/upper 95% CI of mean 39.5/47.72 42.37/53.71 33.17/44.79 10.55/15.13 P values (Wilcoxon) .0091a .4316 .0020a .8457
↵a Significant difference.